Effects of rosiglitazone, an antidiabetic drug, on Kv3.1 channels

Rosiglitazone is a thiazolidinedione-class antidiabetic drug that reduces blood glucose and glycated hemoglobin levels. We here investigated the interaction of rosiglitazone with Kv3.1 expressed in Chinese hamster ovary cells using the wholecell patch-clamp technique. Rosiglitazone rapidly and rever...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Korean journal of physiology & pharmacology 2023-01, Vol.27 (1), p.95-103
Hauptverfasser:	Hyang Mi Lee, Seong Han Yoon, Min-Gul Kim, Sang June Hahn, Bok Hee Choi
Format:	Artikel
Sprache:	kor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!